Our previous studies have shown that suppression of survivin expression or function by plasmid vectors encoding antisense survivin or survivin dominant-negative (DN) mutant (Cys84Ala) can inhibit gastric cancer carcinogenesis and angiogenesis in vivo [22]. This evidence concerns the gene BIRC5 and gastric cancer.